Agios Pharmaceuticals AGIO
NASDAQ AGIO
$37.00 -0.19 (-0.51%)
At close: Oct 23, 2026 · 4:00 PM EDT

Agios Pharmaceuticals (AGIO) Cost of Revenue (2018 - 2026)

Updated

Agios Pharmaceuticals (AGIO) posted Cost of Revenue of $3 million for Q2 2026, up 76.0% from $1.7 million a year earlier and up 127.1% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Cost of Revenue (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Agios Pharmaceuticals was $7.87 million, up 63.0% year-over-year; for FY2025, it came in at $6.35 million, up 52.3% from FY2024.

  • Annual Cost of Revenue has increased for three consecutive years, with a three-year compound annual growth rate of 55.0% (FY2022 to FY2025).
  • In prior years, Agios Pharmaceuticals' Cost of Revenue was $4.17 million in FY2024 (+44.6%), $2.88 million in FY2023 (+69.1%) and $1.7 million in FY2022.
  • The Q2 2026 figure stands as the highest quarterly Cost of Revenue in data going back to Q3 2018.
  • On a year-over-year basis, Cost of Revenue has increased in each of the last 14 quarters, with growth averaging 60.8% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Cost of Revenue ranged from 13.2% (Q1 2024) to 154.7% (Q2 2023).
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $1.32 million (Q1 2026), $1.88 million (Q4 2025) and $1.68 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Agios Pharmaceuticals 2.21 Bn -956.52 Mn 41.75 Mn 3.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.00 Mn
Mar 31, 2026 1.32 Mn
Dec 31, 2025 1.88 Mn
Sep 30, 2025 1.68 Mn
Jun 30, 2025 1.70 Mn
Mar 31, 2025 1.09 Mn
Dec 31, 2024 1.26 Mn
Sep 30, 2024 783,000.00
Jun 30, 2024 1.50 Mn
Mar 31, 2024 627,000.00
Dec 31, 2023 586,000.00
Sep 30, 2023 633,000.00
Jun 30, 2023 1.11 Mn
Mar 31, 2023 554,000.00
Dec 31, 2022 413,000.00
Sep 30, 2022 517,000.00
Jun 30, 2022 435,000.00
Mar 31, 2022 339,000.00
Dec 31, 2020 -1.85 Mn
Sep 30, 2020 638,000.00
API Access

Agios Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AGIO&period=max&api_key=YOUR_API_KEY